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In the human T-cell ymphoma line. HUT 78. proliferation and phorbol eslcr-induced growth arrest and dircremiation were inhibited by the protein 
kinase C (PKC) inhibitor, staurosporine. l3y contrast, an alternative PKC inhibitor, H-7, inhibited proliferation but not phorbol ester-induced 
growth arrest. The cell line was found to contain both a and j? isoforms of PKC by Western blot tcchniqucs, A cell line, K-4, was cloned from 
HUT 78 in the presence of H-7 and this clone was found to be positive for PKC-o only. PKC-p did noi return on cultivation in the abscncc of H-7. 
Proliferation of K-4 was insensitive to inhibition with both H-7 and staurosporine, However, phorbol ester-induced growth arrest remained 
staurosporinc sensitive. Phorbol-stimulated IL-2 secretion was minimal in the PKC-,&deficicm cell line. These data suggest thal PKC-j may be 
a regulatory enzyme for proliferation and stimulated intcrleukin-2 secretion in HUT 78 cells, Heicrogcneity of responses to PKC activation may 
r&l&t the use of different isozymes in different intracellular pathways. The K-4 cell line should provide a useful tool in the disseciion of involvement 
of PKC isozymcs in cellular function, 
Protein kinase C; T lymphocyte; Intcrlcukin ?; Staurosporine: H-7; DilTeremiation; Proliferation 
1. INTRODUCTION 
The protein kinase C (PKC) family of enzyme is in- 
volved in a wide range of cellular functions including 
regulation of cell proliferation and stimulus-secretion 
coupling. PKC appears to be coupled to a multiplicity 
of receptors via the generation of diacylglycerols, the 
physiological ligands for PKC [I], In addition, the so- 
called tumour promoters, including phorbol esters and 
others, appear to function by acaivation of protein ki- 
nase C [2]. Thus, resting T-cells can be induced to pro- 
liferate in the presence of phorbol esters [3], and this 
proliferation may be blocked by protein kinase C inhib- 
itors 141. It is notable, however, that tumour cells un- 
dergo growth arrest and differentiation when stimulated 
with phorbol esters. K-562 cells differentiate to become 
erythrocytes [5] while HL-60 cells differentiate to be- 
come mature cells of the monocyte macrophage series 
[6]. Similarly, complex effects may be noted in the regu- 
lation of IL-2 secretion [73. We have previously reported 
that PMA-induced IL-2 secretion was mediated 
through a pathway insensitive to the protein kinase C 
inhibitor, H-7 in HUT 78 ceils. IL-2 secretion was inhib- 
ited by H-7 in the Jurkat cell line, suggesting the exis- 
tence of multiple pathways for the generation of IL-2 
secretion [4]. Thus, protein kinase C isozymes may me- 
diate diverse ffects, both up-regulating and down-regu- 
lating control of proliferation and secretion, either by 
utilization of different isozymes, transacting elements or 
substrates. Studies based on cloning of the PKC gene 
have demonstrated that PKC comprises a family of re- 
lated enzymes comprising three conventional isoforms, 
tc, p and y, and four novel isoforms some of which are 
calcium independent (6, E, 11, 0 [S]. However, specific 
roles have not as yet been assigned to individual 
isozymes. 
In this study we have generated a clone of the HUT 
78 cell line deficient in the PKC-p isozyme xpressed in 
the parent line. We reasoned that the selection of the cell 
line in the presence of the protein kinase C inhibitor H-7 
would permit the selection of variants which would not 
require one or more PKC isozymes for proliferation. 
This cell line, K-4, provides a useful tool for the study 
in more detail of the heterogeneity ofenzyme utilisation 
in proliferation, PMA-induced growth arrest and inter- 
leukin-2 secretion. 
2. MATERIALS AND METHODS 
2. I. Arrtilwdies uttd cdl lines 
The HUT 78 ccl1 line was oblained from ATCC. Antibodies to CD3 
(Lcu 4), CD4 (Lcu 3), CD8 (Leu 2~). T-cell receptor c@ (WT31) were 
oblained from Bccklon Dickinson, Antibodies IO PKC isozymes were 
obtained from Seikugaku America, Rockville, MD. All cell cultures 
were performed in RPM1 1640 containing 10% foetal caif serum, 2 
mM L-glutamine and 5 x 10e5 M 2-mercaptoethanol (complete mc- 
dium), 
Correspondettcr address: D. Kcllchcr, Dept. of Clinical Medicine. 
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HUT 78 cells were cultivated in the prcscnceofH-7(50pM). Surviv- 
ing cells were then cultivated in complete medium in the presence of 
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H-7 (100 PM). A cell line derived from these cultures was cloned at 
a concentration of l/3 cell per well in compleu medium containing 100 
,uM H-7 in the abscncc of fcedcr cells. One clone, K-4, was selected 
for further study based on its rapid growth rate in H-Fcontaining 
medium. Following selection in H-7 this cc8 line was maintained in 
complcie medium. Cells used for further studies wcrc maintained in 
culture in the absence of H-7, 
2.3. Pk?llolyJte uttdysis 
Cells were surfacc-labelled with murinc monoclonal entibodics 
using Ruoresceinatcd rabbit anti-mouse immunoglobulin (Dekopatts) 
as the second antibody. Data were gathered using a Bcckton Dickin- 
son FACSCAN Ruorescent cell analyser and analyscd using Consort 
30 software, 
HLT 78 or K-4 cells were incubated in 96.well gut-bottomed mi- 
crotitrc plates at a concentration of 2x 10J cells/well for 24 h and 
pulsed with tritiatcd thymidinc (0.5 ~Cilwcll) for the last 6 h of incu- 
bation, PMA at varying concentrations was added at the start of 
incubation and inhibitors added 30 min prior to the addition of PMA. 
Samples were harvested on a multiple automated cell harvester and 
counted in a Beckman liquid scintillation counter. 
HUT 78 or K-4 cells plated at IO”/nrl in 0.1 or 0.2 ml volumes in 
96.well U-bottomed plates were stimulated with titrated connntra- 
tions of PMA (Sigma, St Louis, MO) in the prcscncc or abscncc ofthe 
enzyme inhibitor, H7 (Seikagaku America Inc. Rockvillc, MD), or 
staurosporine (Calbiochem, La Jolla, CA). After I8 h supernatants 
were harvested, iluted and assayed for IL-2 using a CTLL line bioas- 
say as described previously [4], Spccilicity of the assuy for IL-2 was 
verified by blocking uf proliferation with antibody to the IL-1 receptor 
(7D4) and antibody to IL-? (DMS-I). 
Immunoblot analysis of PKC isozymcs using monoclonal antibod- 
ies was performed as follows. HUT 78 or K-4 cells were wushcd in 
phosphate-buffered saline. pH 7.2, cenlrifugcd at 250 x 6 for 5 mitt 
and resuspended in I ml of buffer containing 0.5% NP40, 0.5 mM 
EGTA, 0.1 mM PMSF, lcupeptin IO pg/ml. This lysate was gcnily 
agitated at 4°C for 30 min and ccntrifugcd at ?OO x g for IO min to 
provide a total cellular PKC extract. The :rsullant supernatant was 
then spun at 100,000 x8 for 30 min at 4OC using a Beckman LS-50 
ultracentrifuge equipped with n SW 41 spin-out rotor. Proteins were 
separated by polyacrylumide gel clectrophoresis (10%) and elcctro- 
phoretically transferred to a nitrocellulose mcmbranc. The membrane 
was blocked using Blotto Twecn in phosphate-butfercd saline at pH 
‘i-2 and then incubated with monoclonal antibodies to PKC-r,B and 
y isozymcs in PBS/Blotto Tween for I8 h followed by biotinylated 
sheep anti-mouse antibody (I h) and streptavidin-biotinylated horsc- 
radish pcroxidase complex in I% gelatin for 30 min. lmmunoreactive 
bands were visualised by treatmenl with 3.amino-9-elhylcarbimazolc. 
Molecular weight marker proteins wcrc localised by staining with 
0.2% P0nseau.S in 3% trichioroacclic and 3% sulphosalicylic acid. 
3. RESULTS 
3.1. Pilcrzolypr of K-4 
Clone K-4, derived from the HUT 78 line, was chosen 
for further study on the basis of its growth rate in me- 
dium containing H-7. K-4 proliferated in RPM1 con- 
taining 100 AM H-7 at rates of growth simi!ar to that 
in H-7 free medium. Tine phenotype of K-4 was qualita- 
tively identical with that of the parent HUT 78 cell line 
(Table I). It expressed CD3, T-cell receptor cy3 form and 
Table I 
Phenotype of cell lines used in this study 
-.-.- 
Antibody Cell lines 
HUT 78 K-4 
CD3 (OKT3) 78 77 
TCR a/9 90 76 
TCR yS 0 0 
HLA DR 91 95 
HLA DQ 89 91 
HLA DP 91 99 
LFA-I 99 NT 
TfR 99 90 
Phcnolypc of HUT 78 and clone K-4, Data rcprescnt percentage pas- 
itivc staining cells on indirect immunolluoresccnce. The second anti- 
body used was a tluoresceinated rabbit anti-mouse Fab? fragment. 
Fluoresccncc was analysed on a Beckton Dickinson FACSCAN using 
Consort 30 software. All antibodies used are as referred to inthe text. 
TIR rcprcscnts transferrin receptor. NT, not tested. 
HLA Class il molecules. In addition, HLA typing by 
microcytotoxicity showed K-4 to have the same HLA 
phenotype as the parent HUT 78 line. However, there 
were clear differences between HUT 78 and K-4 with 
respect to PKC isozyme xpression (Fig. 1). In HUT 78, 
both a and /I isozymes were present. Trace amounts of 
a 78 kDa fragment reactive with antibody to the y 
isozyme were seen on some immunoblots. However in 
K-4 cells there was no detectable @or y isozyme and the 
a isozyme was detected asa doublet with a second band 
of slightly lower mol. wt. This low mol. wt. species was 
found to be associated with the plasma membrane (data 
not shown), 
It is apparent from Fig . 2 that proliferation of HUT 
78 was inhibited to approximately 50% of baseline val- 
ues by high concentrations of the protein kinase C in- 
hibitor, staurosporine. When PMA was added differen- 
tiation of HUT 78 took place with loss of expression of 
transferrin receptor (data not shown) and the develop- 
ment of dendritic processes 191. Significantly there was 
virtually complete growth arrest with consequent recluc- 
tion in thymidine incorporation. This process of growth 
arrest was also antagonised by staurosporine, and this 
resulted in restoration of proliferation to approximately 
50% of normal background proliferation. These data 
indicate that staurosporine inhibits both resting prolif- 
eration and PMA-induced growth arrest in HuT 78 
cells. Similar effects on proliferation were seen with H-7 
(Fig. 2b) but H-7 was not able to over-ride the down- 
regulatory effect of PMA on proliferation. 
K-4 cells had been selected for their ability to grow 
in the presence of a potent PKC inhibitor H-7. Thus, 
not surprising!y, K-4 cells were capable of proliferating 
in inhibitory concentrations of staurosporine (Fig. 2~). 
However, PMA was still capable of inducing growth 
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Fig, 1. Immunoblotting of protein kinase C isoymes from the K-4 clone (a-d) and from the HUT 78 parent line (e-h). a and e are stained with 
a monoclonal antibody to PKC-a, b and f with anti-PKC-,8. c and g with anti-PKC-y and d and h arc controls. The dominant bands at 82-84 
kDa are arrowed. 
arrest in this cell line. Growth inhibition was reversed this cell line; however, growth arrest was now somewhat 
by staurosporine suggesting that the enzyme involved H-7 sensitive (Fig. 2d), possibly suggesting that H-7 
in PMA-induced growth arrest is distinct from that in- may have been i ducing growth arrest in the parent line 
volved in stauroaporine-sensitive proliferation of the in a manner analogous to that described in neuroblas- 
parent line. Proliferation was no longer H-7 sensitive in toma cells [lo]. 
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Pig, 2. Proliferation and PMA-induced differentiation measured by tritiated thymidine incorporation of HUT 78 (a and b) end K-4 (c and d) in 
the presence of inhibitors. staurosporine (a and c) and H-7 (b and d). PMA dosage key is given in t!le figure. These data are representative of three 
cxperimcnts. 
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Fig. 3. Intcrleukin-2 production by HUT 78 and K-4 in the presence of staurosporine (a) and H-7 (b). IL-2 production is measured using a bio-assay 
based on thymidinc incorporation by lhe CTLL cell line. These data are representative of three experiments. 
3.3. IL-2 secrerion 
In HUT 78, PMA-stimulated IL-2 secretion exhibited 
a biphasic pattern of response to inhibition with stauro- 
sporine. At high concentrations of staurosporine IL-2 
secretion was partially blocked (Fig. 3a). However, at 
lower concentrations of staurosporine DMA-stimulated 
IL-2 secretion b:;1s cnnsiderably enhanced. These data 
could be explained on the baAis of two PMA-responsive 
pathways involved in the regulation of IL-2 secretion in 
this cell line, one of which is H-7 insensitive (Fig. 3b) 
and is involved in the stimulation of IL-2 secretion. 
Down-regulation of IL-2 secretion may represent a sep- 
arate pathway sensitive to inhibition with lower doses 
of staurosporine. Stimulated IL-2 release was consider- 
ably reduced in K-4 cells which lack PKC-p suggesting 
an obligate requirement for PKC-b for stimulated IL-2 
release in this line. This was somewhat paradoxical, 
since IL-2 secretion is not eliminated by H-7 in the 
parent line. However, it is entirely possible that the 
mechanism of stimulated IL-2 release, albeit H-7 insen- 
sitive, requires prior priming in the cycling cell by a 
mechanism dependent on PKC+?. 
4. DISCUSSION 
Previous studies have demonstrated heterogeneity in
expression of PKC isozymes in human T-cc% In one 
such study [l I], two isozymes were characterised using 
hydroxyapatite chromatography. While one of these 
was shown to be a p isozyme using a monoclonal anti- 
body, the second was not characterised. In another 
study utilising T-cell lines, some cells expressed message 
for PKC-a while others expressed message for both 
PKC-CE and -p [12]. However, individuai functions have 
not previously been assigned to PKC isozymes in 
human T lymphocytes or in lymphomas. The aims of 
this study were to select cell lines deficient in PKC or 
individual isozymes with the ultimate objective of utili- 
sing such lines to examine individual functions of PKC 
isozymes. We elected to use immunoblot analysis of 
protein product to detect the presence or absence of 
PKC isozymes. Native PKC-B protein product was 
clearly undetectable in K-4 cells even when cultured in 
the absence of H-7. While we have not examined this 
cell line for message, if inhibition was at the level of 
message it wou!d be expected to recover on withdrawal 
of H-7. K-4 cells have similar growth characteristics and 
phenotype to HUT 78. However, they exhibit clear dif- 
ferences in that proliferation is insensitive to inhibition 
with the PKC inhibitors, H-7 and staurosporine, in K-4 
cells. These data suggest hat while PKC-p may be in- 
volved in mitogenesis of the parent line, this isozyme is 
not essential for proliferation. However, neither H-7 
nor staurosporine are specific PKC inhibitors and it is 
possible that their interference with growth characteris- 
tics of HuT 78 is due to inhibition of enzymes other than 
PKC. PMA-induced growth arrest occurred in both HUT 
78 and K-4 providing suggestive vidence that the 
growth arrest function is mediated by the t% isozyme. 
This view is supported by the finding that clones se- 
lected for growth in PMA at high ccncentraiions were 
found to be deficient in the 01 isozyme (unpubiished 
observations). Furthermore, in B-cell studies differenti- 
ation of b-cells is accompanied by loss of PKC-,9 and 
expression of increased levels of a suggesting a specific 
role for this isozyme in differentiation [ 131. 
These data in total demonstrate a clear separation in 
the nature of :he PKC isozymes involved in cell prolifer- 
ation and in PMA-induced growth arrest. Since we have 
previousiy drmonstr&d that all calcium- and phospho- 
lipid-dependent kinase activity was blocked by H-7 in 
HUT 78 [4], these data suggest that the normal forms of 
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PKC-a, -j3 and -y were not essential for proliferation in confirmation will require transfection of K-4 cells with 
the K-4 cell line. These findings may be important since the PKC-j3 gene to confirm involvement of this isozyme 
it has been suggested that PKC inhibitors may be poten- in proliferation and IL-2 secretion, Thus, the K-4 line 
tially useful agents in chemotherapy [14]. Our findings should prove to be a useful tool in the dissection of 
individual functions of PKC isozymes. suggest hat their use may be limited by the dcvelop- 
ment of alternative pathways of mitogenesis. An addi- 
tional lower mol. wt. species of PKC-a was found to be 
associated with the plasma membrane in the K-4 cell 
line. It is notable that a mutant PKC-a molecule con- 
taining 4 point mutations preferentially associated with 
the plasma membrane and was found to function as an 
oncogene in transforming human fibroblasts [15] al- 
though this was not confirmed by other workers [16]. 
Hence it is possible that proliferation of the K-4 cell iine 
is regulated by an inhibitor-insensitive membrane-asso- 
ciated transforming variant of PKC-a. Our findings are 
complementary to data from Isakov et al. [173. In their 
study, a T-cell line adapted to survive in PMA was 
found to have reduced expression of PKC-a and to have 
lost expression of CD3. In K-4 cells, loss of PKC-j? did 
not result in loss of PMA-induced differentiation and 
did not result in absence of CD3 expression, supporting 
the hypothesis that PMA-induced differentiation may 
be regulated by PKC-a:. Stimulated IL-2 ‘release was 
considerabiy reduced in K-4 cells which lack PKC-p 
suggesting an obligate requirement for PKC-p in this 
function. However, in order to confirm this requirement 
it will be necessary to perform transfections of the PKC- 
p isozyme back into the isozyme-deficient variants. 
While we have examined only three isoforms of PKC 
in this study, recent work has demonstrated further 
isoforms of PKC [18], including calcium-independent 
forms [ 191. These data suggest that cellular responses to 
stimulation with phorbol esters are complex and repre- 
sent the summation of effects on multiple isoforms 
which may operate on mutually antagonistic pathways. 
Furthermore, these data indicate that different enzymes 
were involved in proliferation and growth arrest in HUT 
78 and suggest hat PKC-a may be the critical isozyme 
in PMA-induced growth arrest. The reduction in IL-2 
secretion and the loss of sensitivity to inhibition of pro- 
liferation seen in K-4 cells suggest hat these functions 
may be mediated by PKC-B in the parent line. Definitive 
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